ストックスクリーナーアプリを入手
23.77
1.60%
0.375
アフターアワーズ：
23.95
0.185
+0.78%
Structure Therapeutics Inc Adr (GPCR) 最新ニュース
Structure Therapeutics (NASDAQ:GPCR) Sets New 12-Month LowWhat's Next? - MarketBeat
Structure Therapeutics Inc. (NASDAQ:GPCR) Sees Large Decline in Short Interest - MarketBeat
GPCR Stock Hits 52-Week Low at $23.48 Amid Market Challenges - Investing.com Canada
Structure Therapeutics (NASDAQ:GPCR) Sets New 52-Week Low – Here’s What Happened - Defense World
Why Structure Therapeutics Stock Was Stumbling This Week - The Globe and Mail
abrdn plc Sells 45,695 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Financial Fitness Check: Examining Structure Therapeutics Inc ADR (GPCR)’s Key Ratios - The Dwinnex
Spire Wealth Management Acquires Shares of 8,949 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Trading Down 6.7%Should You Sell? - MarketBeat
HSBC Securities Downgrades Morgan Stanley (MS) to a Hold from a Buy - Knox Daily
JD.com Inc ADR (JD) receives an Outperform rating from Bernstein - Knox Daily
Ratio Examination: Bausch Health Companies Inc (BHC)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - MarketBeat
Understanding the Recent Fluctuations of Structure Therapeutics Inc ADR’s (GPCR) Stock - The News Heater
Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Update - MarketBeat
CCG Wealth Management LLC Makes New $4.07 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - Defense World
GLP-1 Agonists Weight Loss Drugs Market Size Report, 2030 - Grand View Research
Short Interest in Structure Therapeutics Inc. (NASDAQ:GPCR) Rises By 5.8% - Defense World
Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 8.3%Still a Buy? - MarketBeat
Structure Therapeutics Lines Up Triple Conference Appearances: What's Next for GPCR? - StockTitan
Fidelity Electric Vehicles and Future Transportation ETF (BATS:FDRV) Shares Up 0.5% – Still a Buy? - Defense World
Liberty TripAdvisor (NASDAQ:LTRPA) Now Covered by Analysts at StockNews.com - Defense World
ImmuPharma (LON:IMM) Trading 13.6% Higher – Here’s What Happened - Defense World
JPMorgan Chase & Co. Has $1.31 Million Stock Holdings in iShares International Treasury Bond ETF (NASDAQ:IGOV) - Defense World
JPMorgan Chase & Co. Grows Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Air T (NASDAQ:AIRT) Shares Cross Below 200-Day Moving Average – What’s Next? - Defense World
JPMorgan Chase & Co. Acquires 25,500 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Analysts Issue Forecasts for Kits Eyecare Q4 Earnings - Defense World
Hepion Pharmaceuticals Announces $9M Public Offering with Dual Warrant Structure - StockTitan
Morningstar Mobile - Morningstar
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs - Morningstar
Savills (OTCMKTS:SVLPF) Trading Down 5.2% – What’s Next? - Defense World
Novo’s Ozempic, Wegovy Targeted for Medicare Price Cuts - BNN Bloomberg
GAMMA Investing LLC Raises Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Schrödinger Secures $150M Novartis Deal, Advances Three Clinical Programs for 2025 - StockTitan
Structure Therapeutics (NASDAQ:GPCR) Hits New 1-Year LowShould You Sell? - MarketBeat
Nucor Towers & Structures Announces Expansion of Footprint - Yahoo Finance
Stifel Nicolaus Begins Coverage on Structure Therapeutics (NASDAQ:GPCR) - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Structure Therapeutics (NASDAQ:GPCR) Shares Gap UpHere's What Happened - MarketBeat
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):